The Effect of Humiome® Post LB on Gut COMFort in healthY Adult Volunteers

The goal of this double-blind, randomized placebo-controlled study is to evaluate the effect of an 8-week supplementation of Humiome ® Post LB (170 mg) on bowel movements in healthy adult volunteers compared to Placebo adjusted on baseline. The main question\[s\] it aims to answer \[is/are\]: Does Humiome ® Post LB improve bowel movements with self-reported GI issues? Participants will be provided Humiome ® Post LB (170 mg) for 8 weeks and asked to complete a study diary, questionnaires, and stool samples.

NCT Number	NCT06937814
Lead Sponsor	dsm-firmenich Switzerland AG Collaborators: KGK Science Inc.
Conditions	GI Issues, Bowel Movements, Gastrointestinal Symptoms
Enrollment	250 participants
Start Date	2025-06-16
Primary Completion	2027-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-08